日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC

肿瘤细胞FAP在侵袭性局限性透明细胞肾细胞癌中调控EMT和免疫抑制。

Pellinen, Teijo; Luomala, Lassi; Mattila, Kalle E; Hemmes, Annabrita; Välimäki, Katja; Arjama, Mariliina; Brück, Oscar; Paavolainen, Lassi; Kankkunen, Elisa; Nisén, Harry; Järvinen, Petrus; Castillon, Leticia; Vanharanta, Sakari; Vainio, Paula; Kallioniemi, Olli; Jaakkola, Panu M; Mirtti, Tuomas

Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities

对离体前列腺癌CAF模型进行分子谱分析,可以揭示基质异质性和药物敏感性。

Rantanen, Frida; Murumägi, Astrid; Arjama, Mariliina; Välimäki, Katja; Multamäki, Elina; Mirtti, Tuomas; Rannikko, Antti; Pellinen, Teijo; Ungureanu, Daniela; Kallioniemi, Olli

Multidrug resistant Acinetobacter baumannii: A study on its pathogenesis and therapeutics

多重耐药鲍曼不动杆菌:致病机制和治疗研究

Mukhopadhyay, Hridesh; Bairagi, Arnab; Mukherjee, Anushka; Prasad, Aman Kumar; Roy, Arjama Dhar; Nayak, Aditi

Ethical Issues Encountered by Nurse Managers Working With Older Adults in Long-Term Care Settings: A Qualitative Interview Study

长期护理机构中护士管理者在照顾老年人时遇到的伦理问题:一项定性访谈研究

Arjama, Anna-Liisa; Suhonen, Riitta; Kangasniemi, Mari

Ethical issues in long-term care settings: Care workers' lived experiences

长期护理机构中的伦理问题:护理人员的亲身经历

Arjama, Anna-Liisa; Suhonen, Riitta; Kangasniemi, Mari

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

卵巢癌组织学亚型中患者来源癌细胞的药物反应概况:针对低级别浆液性癌患者的实时治疗定制

Astrid Murumägi, Daniela Ungureanu, Suleiman Khan, Mariliina Arjama, Katja Välimäki, Aleksandr Ianevski, Philipp Ianevski, Rebecka Bergström, Alice Dini, Anna Kanerva, Riitta Koivisto-Korander, Johanna Tapper, Heini Lassus, Mikko Loukovaara, Andrus Mägi, Akira Hirasawa, Daisuke Aoki, Vilja Pietiäine

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention

多组学表征表明PTK7参与卵巢癌的EMT和细胞可塑性,并为治疗干预提供了策略。

Raivola, Juuli; Dini, Alice; Karvonen, Hanna; Piki, Emilia; Salokas, Kari; Niininen, Wilhelmiina; Kaleva, Laura; Zhang, Kaiyang; Arjama, Mariliina; Gudoityte, Greta; Seashore-Ludlow, Brinton; Varjosalo, Markku; Kallioniemi, Olli; Hautaniemi, Sampsa; Murumägi, Astrid; Ungureanu, Daniela

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models

E-钙粘蛋白是结直肠癌中可靠的预后生物标志物,在临床前模型中,低表达与对拓扑异构酶、Aurora 和 HSP90 抑制剂的敏感性有关

Jarle Bruun, Peter W Eide, Christian Holst Bergsland, Oscar Bruck, Aud Svindland, Mariliina Arjama, Katja Välimäki, Merete Bjørnslett, Marianne G Guren, Olli Kallioniemi, Arild Nesbakken, Ragnhild A Lothe, Teijo Pellinen

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma

高通量体外药物检测可识别 NRAS 阳性恶性黑色素瘤的潜在药物和药物组合

Laura Kohtamäki, Mariliina Arjama, Siru Mäkelä, Philipp Ianevski, Katja Välimäki, Susanna Juteau, Suvi Ilmonen, Daniela Ungureanu, Olli Kallioniemi, Astrid Murumägi, Micaela Hernberg

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cells

STRN-ALK 重排儿童恶性腹膜间皮瘤 - 527 种抗癌药物在患者来源的癌细胞中的功能测试

Astrid Murumägi, Daniela Ungureanu, Mariliina Arjama, Ralf Bützow, Jouko Lohi, Hannu Sariola, Jukka Kanerva, Minna Koskenvuo, Olli Kallioniemi